Sambilad, Avrianna B.

HRN: 23-73-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2025
CEFUROXIME 750MG (VIAL)
08/30/2025
09/06/2025
IV
370mg
Q8
PCAPC
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines